医疗用微晶片的全球市场:现状分析与预测(2022年～2028年)

全球医疗用微晶片市场，由于医药品的投资和临床试验增加，预期稳定成长约11％。再加上医疗用微晶片技术的技术不断进步，在预测期间内预计对市场成长产生很大的影响。

本报告提供全球医疗用微晶片市场相关调查分析，市场概要，各市场区隔、各地区的市场分析，市场成长的影响因素，市场趋势，竞争情形，主要企业简介等彙整资讯。

目录

第1章 市场简介

第2章 调查手法、前提

第3章 市场概要

第4章 摘要整理

第5章 COVID-19对医疗用微晶片市场的影响

第6章 医疗用微晶片市场收益(2020年～2028年)

第7章 市场洞察:各用途

• 药物输送
• 家庭监控
• 其他

第8章 市场洞察:各类型

• 医院
• 研究中心
• 其他

第9章 市场洞察:各地区

• 北美
  • 美国
  • 加拿大
  • 其他北美
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 其他欧洲
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 全球其他地区

第10章 医疗用微晶片的市场动态

• 推动市场要素
• 市场课题
• 影响分析

第11章 医疗用微晶片的市场机会

第12章 医疗用微晶片的市场趋势

第13章 需求侧和供给侧的分析

• 需求面分析
• 供给侧分析

第14章 价值链分析

第15章 价格分析

第16章 策略性洞察能力

第17章 竞争模式

• 竞争情形
  • 波特的五力分析

第18章 公司概要

• INTROMEDIC
• Otsuka America Pharmaceutical, Inc.
• Applied Microarrays, LLC
• QIAGEN
• Agilent Technologies, Inc.
• Medtronic
• Illumina, Inc.
• BGI
• Macrogen, Inc.
• Bio-Rad Laboratories, Inc.

第19章 免责声明

Medical implant makers incorporate chemicals or medications with the purpose of increasing efficacy and morbidity. Microchips are a novel technology that enables the on-demand delivery of diverse medications over long durations using several reservoirs with discrete pharmacological doses. The global microchips in medicine market is growing at a tremendous rate owing to rising life-threatening diseases, such as specific types of cancers, neurological disorders, and pediatric and rare diseases. For instance, according to the data published by the American Cancer Society (ACS), in January 2020, around 1.8 million new cancer cases were diagnosed and 606,520 cancer deaths in the United States

The microchips in medicine market is expected to grow at a steady rate of around 11% owing to the increasing growing investment and clinical trials of these medicines. Furthermore, growing technological advancements in microchips in medicine technology is expected to significantly influence the market growth over the forecast period.

Based on application, the market is segmented into drug delivery, home monitoring, and others. Among them, the drug delivery category is to witness higher CAGR during the forecast period owing to the growing demand for enhanced drug delivery systems, which have advantages such as improving the consumption of active pharmaceutical ingredients, reducing dosage frequency, and minimizing adverse/side effects which will further drive the growth of the segment.

On the basis of end-user, the market is categorized into hospitals, research centers, and others. Among these, the hospital held a significant share of the market in 2020. This is mainly due to rising patient administration in hospitals with various neurological diseases, chronic diseases, and rare disorders boosting segmental growth. For instance, according to the Brain Aneurysms Foundation, about 30,000 people in the United States suffer a brain aneurysm rupture each year.

For a better understanding of the market adoption of the microchips in medicine industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. owing to the continuous technological developments by key players, high investment in R&D, availability of technologically advanced healthcare infrastructure, rising need for technology in medicine development for diagnosis purposes, and the presence of several government initiatives in the U.S. and Canada support research in drug development and treatment of various life-threatening diseases.

Some of the major players operating in the market include: INTROMEDIC; Otsuka America Pharmaceutical, Inc.; Applied Microarrays, LLC; QIAGEN; Agilent Technologies, Inc.; Medtronic; Illumina, Inc.; BGI; Macrogen, Inc.; Bio-Rad Laboratories, Inc.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Microchips in Medicine Market
• 2.2. Research Methodology of the Microchips in Medicine Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE MICROCHIPS IN MEDICINE MARKET

6 MICROCHIPS IN MEDICINE MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY APPLICATION

• 7.1. Drug Delivery
• 7.2. Home Monitoring
• 7.3. Others

8 MARKET INSIGHTS BY TYPE

• 8.1. Hospital
• 8.2. Research Centers
• 8.3. Others

9 MARKET INSIGHTS BY REGION

• 9.1. North America
  • 9.1.1. U.S.
  • 9.1.2. Canada
  • 9.1.3. Rest of North America
• 9.2. Europe
  • 9.2.1. Germany
  • 9.2.2. U.K.
  • 9.2.3. France
  • 9.2.4. Italy
  • 9.2.5. Spain
  • 9.2.6. Rest of Europe
• 9.3. Asia-Pacific
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. India
  • 9.3.4. Rest of Asia-Pacific
• 9.4. Rest of World

10 MICROCHIPS IN MEDICINE MARKET DYNAMICS

• 10.1. Market Drivers
• 10.2. Market Challenges
• 10.3. Impact Analysis

11 MICROCHIPS IN MEDICINE MARKET OPPORTUNITIES

12 MICROCHIPS IN MEDICINE MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

• 13.1. Demand Side Analysis
• 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 PRICING ANALYSIS

16 STRATEGIC INSIGHTS

17 COMPETITIVE SCENARIO

• 17.1. Competitive Landscape
  • 17.1.1. Porters Fiver Forces Analysis

18 COMPANY PROFILED

• 18.1. INTROMEDIC
• 18.2. Otsuka America Pharmaceutical, Inc.
• 18.3. Applied Microarrays, LLC
• 18.4. QIAGEN
• 18.5. Agilent Technologies, Inc.
• 18.6. Medtronic
• 18.7. Illumina, Inc.
• 18.8. BGI
• 18.9. Macrogen, Inc.
• 18.10. Bio-Rad Laboratories, Inc.

19 DISCLAIMER